Pyrrolidine and pyrroline derivatives having effects on serotonin related systems
申请人:Eli Lilly and Company
公开号:US06353008B1
公开(公告)日:2002-03-05
The present invention provides the compounds of the following formula (I):
and a method for inhibiting the reuptake of seretonin, antagonizing the 5-HT1A receptor and antagonizing the 5-HT2A receptor which comprises administering to a subject in need of such treatment an effective amount of formula (I).